First-in-Class Drug Approved for IgA Nephropathy

Published Date: 09 Jul 2026

It has not been established whether atacicept slows kidney function decline long-term, however

Read Full News

Latest News

IgA Nephropathy: From Clinical Suspicion to Definitive Diagnosis

IgA Nephropathy: From Clinical Suspicion to Definitive Diagnosis

Recognizing the Manifestations and Multidimensional Impacts of Sjögren's Disease

Recognizing the Manifestations and Multidimensional Impacts of Sjögren's Disease

Exploring Underlying Pathogenesis in Sjögren's Disease and a Rapidly Expanding Therapeutic Landscape

Exploring Underlying Pathogenesis in Sjögren's Disease and a Rapidly Expanding Therapeutic Landscape

New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications

New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications

Navigating New Guidelines in IgA Nephropathy

Navigating New Guidelines in IgA Nephropathy

Advances in Post-Kidney Transplant Immunosuppression: Applying the Latest CNI-Sparing Strategies to Optimize Long-Term Outcomes

Advances in Post-Kidney Transplant Immunosuppression: Applying the Latest CNI-Sparing Strategies to Optimize Long-Term Outcomes

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Todays Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Latest News

IgA Nephropathy: From Clinical Suspicion to Definitive Diagnosis

Recognizing the Manifestations and Multidimensional Impacts of Sjögren's Disease

Exploring Underlying Pathogenesis in Sjögren's Disease and a Rapidly Expanding Therapeutic Landscape

New and Emerging Therapies in IgA Nephropathy: Latest Data and Clinical Implications

Navigating New Guidelines in IgA Nephropathy

Advances in Post-Kidney Transplant Immunosuppression: Applying the Latest CNI-Sparing Strategies to Optimize Long-Term Outcomes

News All Time

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Ushering in a New Era of IgAN Care: Targeted Therapies and Evolving Guidelines

Navigating New Guidelines in IgA Nephropathy

Navigating New Guidelines in IgA Nephropathy

FDA Greenlights Novel Hypertension Pill for Tough-to-Treat Patients

Aldosterone synthase inhibitor baxdrostat indicated as add-on to other antihypertensives

CAR T-Cell Therapy Enabled Kidney Transplant in Highly Sensitized Patients

Strategy offers hope for hard-to-match patients

Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD

Trial finds risk, but no benefit, with blood thinner

When Should Our Patients With Diabetes Eat?

Meal timing may be an underused tool

Measured GFR in Line With eGFR for Predicting CKD Outcomes

Combining creatinine and cystitis C offered best accuracy for estimated calculations

B-Cell Depleter Nabs Phase III Win in Autoimmune Kidney Disease

Obinutuzumab tops immunosuppressant tacrolimus for membranous nephropathy remissions

Video: Police Tussle With Diabetes Experts at ADA Meeting

Researchers told they could no longer attend the annual scientific sessions

Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide

But its key advantage is in its weight reduction abilities

Finerenone Also Slows Kidney Decline in Diabetes-Free Patients

Benefits were consistent across glomerular disease subtypes, too

Monthly GLP-1 for Obesity Promising as More Manageable Alternative

Less frequent dosing could support better long-term adherence, says researcher

GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials

Phase III trials back CagriSema in different type 2 diabetes populations

APOL1 Gene and Focal Segmental Glomerulosclerosis

Genetic variants tied to increased risk are only found in those of African decent

Make the Diagnosis: Chest Pain, Dyspnea, Palpitations, and More: What’s Her Diagnosis?

A 45-year-old woman presented to the emergency department with complaints of chest pain, heart palpitations that developed earlier that day, and dyspnea that began 3 days prior and had progressed. Can you diagnose the patient?

Rewriting What We Know About Kidney Transplant Rejection

Rewriting What We Know About Kidney Transplant Rejection

Recommended News For You

Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma

Combination therapy improves outcomes for advanced triple-negative breast cancer

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.

What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?

An Intimate Life of Medical Innovation and Charity.

Annual whole-body, low-dose CT aids management of smoldering multiple myeloma

Recommended Articles For You

Rehabilitation of Hand Dexterity Following Hematologic Treatment-Associated Deconditioning 

Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers 

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice 

From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do Anatomy Atlases Reflect Social Inequalities?

2.

In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.

3.

Mammography with AI support is a secure method for detecting breast cancer.

4.

QOL Maintained With Giredestrant Combo in Advanced BC

5.

Talc Powder Not Linked to Lung Cancer in Women

1.

Tumor Ecosystem Rewiring Through Adaptive Therapeutics

2.

Seeing the Unseen: Examining Chancroid Through Images

3.

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies 

4.

The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology

5.

Decoding Granular Cell Tumor: What You Need to Know

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Advances in Modern Cancer Treatment

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

3.

Thromboprophylaxis In Medical Settings

4.

Navigating the Complexities of Ph Negative ALL - Part VII

5.

Managing Common Side Effects During Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot